Natixis Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Natixis Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-22,310	Closed	-$434K	–	1126
2018 Q1	$434K	Buy	22,310 +6,118	+38%	+$120K	﹤0.01%	1020
2017 Q4	$270K	Buy	+16,192	New	+$297K	﹤0.01%	1018
2014 Q3	–	Sell	-6,933	Closed	-$208K	–	1271
2014 Q2	$208K	Buy	+6,933	New	+$187K	﹤0.01%	1276

Natixis Advisors's IPXL Position: Q2 2018 in Review

Natixis Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 22,310 shares — an estimated $434K sold.

Natixis Advisors first reported a position in IPXL in Q2 2014 and held it in 3 quarters. The position peaked at $434K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Natixis Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Natixis Advisors sold 22,310 Impax Laboratories, Inc. shares in Q2 2018, an estimated $434K.
Natixis Advisors first reported a position in Impax Laboratories, Inc. in Q2 2014 and held it in 3 quarters.
Natixis Advisors's Impax Laboratories, Inc. position peaked at $434K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Natixis Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.